VEGFA and neoplasm: Most importantly, rhabdoid and sarcomatoid differentiations are features more commonly associated with ccRCC and are associated with worst prognosis (62–64); the higher the clear cell component of a patient's tumor, the greater the chances of the patient benefitting from anti-VEGF therapy (65).